Information Provided By: 
Fly News Breaks for November 17, 2015
SPLK
Nov 17, 2015 | 07:33 EDT
RBC Capital expects Splunk's Q3 results to come in slightly above expectations. After surveying resellers, the firm says it heard that the company made three deals over $1M. The firm added that 21% of respondents said they were above plan and 75% were in-line to above. RBC keeps an $85 price target and Outperform rating on the name.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
